← The SEC Ephemeris: the whole map
Amgen Inc. Kanjinti
In the graph: all 8 documents (227 pages).
- Application
- BLA 761073
- Ticker
- AMGN
- Product
- Kanjinti
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- May 25, 2018 · July 13, 2017 · August 27, 2015
From FDA letters and SEC filings. Not investment or medical advice.